Related Experiment Video
Updated: May 12, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes
1School of Chemical Science and Technology, Yunnan University, Kunming, China.
Deeper metabolic phenotyping of type 2 diabetes (T2D) identified distinct subgroups beyond routine clinical variables. This enhanced resolution may improve understanding of T2D heterogeneity, but requires external validation for clinical application.
Area of Science:
- Endocrinology and Metabolism
- Computational Biology
- Precision Medicine
Background:
- Type 2 diabetes (T2D) exhibits metabolic heterogeneity, with existing clustering based on limited clinical variables identifying major subgroups like severe insulin-deficient diabetes (SIDD) and severe insulin-resistant diabetes (SIRD).
- The potential for deeper metabolic phenotyping to refine these classifications and reveal novel T2D subgroups remains underexplored.
Purpose of the Study:
- To investigate whether comprehensive metabolic phenotyping can enhance the resolution of T2D subgroups beyond established low-dimensional frameworks.
- To identify novel, physiologically coherent T2D phenotypes through exploratory cluster analysis.
Main Methods:
- An exploratory cross-sectional cluster analysis was conducted on 94 adults with newly diagnosed T2D using deep metabolic phenotyping data.
- Principal Component Analysis (PCA) informed the selection of 13 key variables across six physiological domains.
- K-means clustering was applied to standardized variables, with robustness assessed using various variable panels and alternative clustering methods.
Main Results:
- Five distinct phenotypic clusters emerged, including one with preserved insulin sensitivity and compensatory hyperinsulinaemia (IS-HI).
- Two clusters corresponded to canonical SIDD-like and SIRD-like phenotypes.
- Two novel clusters were identified: a myogenic-anaemia (MA) phenotype and a hepato-lipotoxic (HL) phenotype, highlighting distinct pathophysiological patterns.
Conclusions:
- Increased phenotypic depth in metabolic profiling can potentially improve mechanistic understanding of T2D heterogeneity beyond routine clinical data.
- These findings are hypothesis-generating and require external validation and longitudinal outcome data before informing clinical decision-making or treatment strategies.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Pharmacogenomics: Identification of New Drug Targets